June 2009
Series B Round
Aqueous Biomedical closes Series B round of financing.

September 2007
Japan Awards Patent
Japan issues patent for ABI's Oculieve glaucoma drainage device.



Aqueous Biomedical Inc. (ABI), is a privately held biomedical device company located in Colorado Springs, Colorado.
Aqueous Biomedical has made new discoveries about how cells respond to chemical interactions and physical forces caused by biomedical implants. Using this knowledge, we are developing unique biocompatible materials and geometric designs that work with the body. This revolutionary approach can be applied across a wide range of technologies, including stents, shunts, artificial organs, and drug delivery devices, to make these implants more effective and longer lasting.


Our first product is the Oculieve™ shunt, uniquely designed to control over-pressurization inside the eye caused by glaucoma and prevent the onset of blindness. We are also currently developing bio-friendly coating materials for cardiovascular stents that prevent restenosis, and modifications for implanted drug delivery devices to prevent scarring and clogging.

Copyright © 2006 Aqueous Biomedical. All Rights Reserved. Website design by